Home › Calculator › MRMD Dividend Calculator 2026
MRMD Dividend DRIP Calculator 2026
3021.15% YieldHealthcareMariMed Inc. · OTC
Price: $0.07 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MRMD pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your MRMD snowball 📈
$10,000 in MRMD → $432.81M in 10 years · $1,039.14/month
About MariMed Inc. (MRMD) — Dividend Analysis 2026
MariMed Inc. operates in the cannabis industry, specializing in the cultivation, production, and sale of both medicinal and adult-use cannabis items throughout the United States and internationally. The company's diverse product portfolio includes cannabis flowers and concentrates marketed under the Nature's Heritage brand. It also offers infused goods such as chewable tablets and powdered drink mixes under the Kalm Fusion label, natural fruit chews known as Betty's Eddies, and a line of baked treats like brownies and cookies available through Bubby's Baked. Furthermore, MariMed develops cannabidiol (CBD) products under the Florance brand. Beyond its own offerings, the company licenses its various brands and product formulations to others and leases facilities designed for cannabis operations. MariMed Inc., founded in 2011, is based in Norwood, Massachusetts.
Compare MRMD with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MRMD DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MRMD position with:
🌍 MRMD Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MRMD.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3021.15% | 3018.35% | $302,115 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2567.98% | 2565.18% | $256,798 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2416.92% | 2414.12% | $241,692 / yr |
| 🇬🇧 UK ISA | 0% | 3021.15% | 3018.35% | $302,115 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2756.80% | 2754.00% | $275,680 / yr |
| 🇨🇦 TFSA | 0% | 3021.15% | 3018.35% | $302,115 / yr |
| 🇨🇦 CA Taxable | 25% | 2265.86% | 2263.06% | $226,586 / yr |
| 🇦🇺 Super (pension) | 15% | 2567.98% | 2565.18% | $256,798 / yr |
| 🇦🇺 AU Taxable | 30% | 2114.80% | 2112.00% | $211,480 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2224.32% | 2221.52% | $222,432 / yr |
| 🇫🇷 FR Taxable | 30% | 2114.80% | 2112.00% | $211,480 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MRMD Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MRMD Dividend Payment Schedule
MRMD pays quarterly — 4 times per year. Next ex-div: TBD.
📊 MRMD vs Healthcare Benchmarks
How MRMD compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MRMD sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MRMD Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-07-15 | 30,625 | — | — | ||
| F-InKind | 2026-07-15 | 10,612 | $0.07 | $703.00 | ||
| M-Exempt | 2026-07-15 | 30,625 | — | — | ||
| M-Exempt | 2026-07-15 | 42,656 | — | — | ||
| F-InKind | 2026-07-15 | 14,781 | $0.07 | $979.00 | ||
| M-Exempt | 2026-07-15 | 42,656 | — | — | ||
| M-Exempt | 2026-07-15 | 32,813 | — | — | ||
| F-InKind | 2026-07-15 | 11,370 | $0.07 | $753.00 | ||
| M-Exempt | 2026-07-15 | 32,813 | — | — | ||
| M-Exempt | 2026-07-15 | 88,276 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MRMD dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
MariMed Inc. (MRMD) is currently trading at $0.07, trading near its 52-week low. The current dividend yield is 3021.15% based on an annual payout of $2.00 per share.
MRMD (MariMed Inc.) — 3021.15% Dividend Yield Analysis
MariMed Inc. (MRMD) is a healthcare stock currently trading at $0.07 with a dividend yield of 3021.15%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, MRMD has grown its dividend at a compound annual rate of 50.0%.
- Above-average yield (3021.15%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.